Altered Cytoplasmic-to-Nuclear Ratio of Survivin Is a Prognostic Indicator in Breast Cancer

PURPOSE: Survivin (BIRC5) is a promising tumor biomarker. Conflicting data exist on its prognostic effect in breast cancer. These data may at least be partly due to the manual interpretation of immunohistochemical staining, especially as survivin can be located in both the nucleus and cytoplasm. Qua...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Cancer Res
Hlavní autoři: Brennan, Donal J., Rexhepaj, Elton, O’Brien, Sallyann L., McSherry, Elaine, O’Connor, Darran P., Fagan, Ailís, Culhane, Aedín C., Higgins, Desmond G., Jirstrom, Karin, Millikan, Robert C., Landberg, Goran, Duffy, Michael J., Hewitt, Stephen M., Gallagher, William M.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2008
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7295090/
https://ncbi.nlm.nih.gov/pubmed/18451232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-07-1760
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky